In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates. - Wikidata - wikimedia - TriplyDB

In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates.

In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates.

http://www.wikidata.org/entity/Q40290234

about

Pleuromutilins: use in food-producing animals in the European Union, development of resistance and impact on human and animal health Flow cytometric determination of the effects of antibacterial agents on Mycoplasma agalactiae, Mycoplasma putrefaciens, Mycoplasma capricolum subsp. capricolum, and Mycoplasma mycoides subsp. mycoides large colony type In vitro susceptibilities of Mycoplasma putrefaciens field isolates Comparison of 2 commercial single-dose Mycoplasma hyopneumoniae vaccines and porcine reproductive and respiratory syndrome virus (PRRSV) vaccines on pigs dually infected with M. hyopneumoniae and PRRSV Low temperature and dust favour in vitro survival of Mycoplasma hyopneumoniae: time to revisit indirect transmission in pig housing.Mycoplasma bovis isolates from dairy calves in Japan have less susceptibility than a reference strain to all approved macrolides associated with a point mutation (G748A) combined with multiple species-specific nucleotide alterations in 23S rRNA.Development of Mycoplasma hyopneumoniae Recombinant Vaccines.In vitro activity of tylvalosin against Spanish field strains of Mycoplasma hyopneumoniae.

P2860

Q27015971-69E6FBCE-F442-478B-9FC4-C2073CBB7A8C Q34973674-09A8E7B9-F46B-4824-8ABC-584FA94FE95D Q36094829-83F1E0E6-A68D-481D-8BA9-77BAB90B4B00 Q36811008-940DA465-B75F-4D0B-9E4B-F1CEF9A03F83 Q39271096-FECF4771-FCEF-456D-8AD4-DD10A14194D2 Q40212926-1D493342-4EAD-43B0-9078-E5F8DD83FADD Q50861611-E8552CDC-233E-45ED-B9C3-EECB8BBDC031 Q51700091-2898A16E-BFF6-4519-A5DA-97BF07AFC4A6

P2860

In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates.

http://www.wikidata.org/entity/Q40290234

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates.

@en

type

label

In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates.

@en

prefLabel

In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates.

@en

P1433

Q40290234-01726D08-42DB-46B1-9C7E-A285A624E45F

P1476

Q40290234-8BA030EC-8620-4A16-9BB8-20F00BEA3617

P2093

Q40290234-1ADE9960-BC5F-4BCE-AFD4-34FD8F477B27

Q40290234-80442530-5416-409E-BEF8-37605A871F96

Q40290234-A0A0C1FC-7B45-4A30-B81F-F1C4202FA95F

Q40290234-CCC0BE94-1326-4488-9802-E25F9D9ECAED

Q40290234-F60C1BA9-03D5-4D5A-9D2B-2AE588621BD5

P2860

Q40290234-06BAEAE9-8DAB-4D46-8DD0-8A92092F7AE5

Q40290234-1D6149E5-BFE5-4758-963C-DED60D7E256B

Q40290234-24A3960C-93EC-4E16-ACBD-2DE7FA2BE71A

Q40290234-323A311F-E477-4528-A391-2DF5B61F017C

Q40290234-334F44B9-0769-40EC-A0F5-95C6CBB85F0F

Q40290234-41E055A7-203B-43BD-A5FE-E2C98566B17D

Q40290234-57354151-D7D2-47CC-930A-CFA1BAC6DA75

Q40290234-64834227-BC4C-4AC1-A728-908DB1BC0A16

Q40290234-78BE0A44-A2A0-4083-B055-9BF8267D3B9C

Q40290234-BD4BAD8E-9432-4B72-AEE1-F3453F361CA1

P304

Q40290234-404BEB65-B8A3-4220-823B-25DAD5BF8E8D

P31

Q40290234-AAAFFF91-5BF0-4672-A6F3-08927F1C458D

P356

Q40290234-991E16AF-AD6D-4CF0-AC1D-3D81B16ABF09

P407

Q40290234-C18687C1-4A95-406D-9486-88D5633A3F48

P433

Q40290234-8D6B37CB-1578-4E33-9FB2-CCE1D500764E

P478

Q40290234-7E1D3DCD-6F5A-4653-89CD-9F977CB2E8AF

P50

Q40290234-42563DAC-AE64-4A80-BF1A-4044B6901835

Q40290234-63607391-0039-4B7E-8F93-23F2619701FE

P577

Q40290234-2EC0E39B-B99B-4946-9BA4-AFE66A3E6236

P698

Q40290234-E9A2C80D-8EB4-43E6-A22F-5102165BEAB1

P932

Q40290234-333C234F-FB7F-4607-998B-4CDF53934503

P356

AAC.48.11.4470-4472.2004

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates.

@en

P2093

A de Kruif

http://www.w3.org/2001/XMLSchema#string

D Maes

http://www.w3.org/2001/XMLSchema#string

J Peeters

http://www.w3.org/2001/XMLSchema#string

J Vicca

http://www.w3.org/2001/XMLSchema#string

T Stakenborg

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis.

Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. International Research Programme on Comparative Mycoplasmology.

Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria.

Macrolide susceptibility of Mycoplasma hyorhinis isolated from piglets.

Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones.

Susceptibilities of Mycoplasma bovis, Mycoplasma dispar, and Ureaplasma diversum strains to antimicrobial agents in vitro

Comparison of methods for in vitro testing of susceptibility of porcine Mycoplasma species to antimicrobial agents.

Insights into erythromycin action from studies of its activity as inducer of resistance.

Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium.

Patterns of Mycoplasma hyopneumoniae infections in Belgian farrow-to-finish pig herds with diverging disease-course.

P304

4470-4472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.48.11.4470-4472.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Freddy Haesebrouck

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15504886

http://www.w3.org/2001/XMLSchema#string

P932

525426

http://www.w3.org/2001/XMLSchema#string